scholarly article | Q13442814 |
P356 | DOI | 10.1074/JBC.270.13.7025 |
P698 | PubMed publication ID | 7706236 |
P50 | author | Anne Durandy | Q42348498 |
P2093 | author name string | Bernard A | |
Graber P | |||
Allet B | |||
Mazzei GJ | |||
Bonnefoy JY | |||
Edgerton MD | |||
Gauchat JF | |||
Losberger C | |||
Lecoanet-Henchoz S | |||
P2860 | cites work | Human CD40‐ligand: molecular cloning, cellular distribution and regulation of expression by factors controlling IgE production | Q24337552 |
Molecular and biological characterization of a murine ligand for CD40 | Q28186605 | ||
A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors | Q28248803 | ||
SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat | Q29620254 | ||
CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells | Q30442717 | ||
Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion | Q31147001 | ||
In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. | Q36362552 | ||
gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory | Q36363299 | ||
The biology of the human ligand for CD40. | Q40385754 | ||
CD40L: a multi-functional ligand | Q40386990 | ||
The Role of CD40 and its Ligand in the Regulation of the Immune Response | Q40391931 | ||
Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)". | Q40625289 | ||
Induction of human IgE synthesis in B cells by mast cells and basophils | Q41526881 | ||
Inhibition of human interleukin 4-induced IgE synthesis by a subset of anti-CD23/Fc epsilon RII monoclonal antibodies | Q41757368 | ||
Identification of a source of biologically active CD40 ligand | Q44877005 | ||
Cloning of TRAP, a ligand for CD40 on human T cells | Q48147375 | ||
Purification and characterization of the DNA-binding protein Ner of bacteriophage Mu. | Q54748264 | ||
Mechanism of antigen-driven selection in germinal centres | Q59072211 | ||
Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome | Q59548368 | ||
A subset of anti-CD21 antibodies promote the rescue of germinal center B cells from apoptosis | Q70623844 | ||
Unraveling function in the TNF ligand and receptor families | Q72393346 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 7025-7028 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Recombinant soluble trimeric CD40 ligand is biologically active | |
P478 | volume | 270 |
Q33193416 | A Salmonella typhi OmpC fusion protein expressing the CD154 Trp140-Ser149 amino acid strand binds CD40 and activates a lymphoma B-cell line. |
Q38295976 | A factor of inducing IgE from a filarial parasite is an agonist of human CD40. |
Q48160439 | Activation of microglial cells by the CD40 pathway: relevance to multiple sclerosis |
Q37873932 | Adjuvants for enhancing the immunogenicity of whole tumor cell vaccines. |
Q74602347 | Analysis of the oligomeric requirement for signaling by CD40 using soluble multimeric forms of its ligand, CD154 |
Q36221538 | Anti-CD 40 monoclonal antibody. |
Q35131181 | Antiplatelet activity of valproic acid contributes to decreased soluble CD40 ligand production in HIV type 1-infected individuals |
Q35788328 | Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions |
Q40843103 | CD154 variant lacking tumor necrosis factor homologous domain inhibits cell surface expression of wild-type protein |
Q40918159 | CD154 variants associated with hyper-IgM syndrome can form oligomers and trigger CD40-mediated signals |
Q47572384 | CD205 antigen targeting combined with dendritic cell recruitment factors and antigen-linked CD40L activation primes and expands significant antigen-specific antibody and CD4(+) T cell responses following DNA vaccination of outbred animals. |
Q24299911 | CD40 Ligand Blocks Apoptosis Induced by Tumor Necrosis Factor α, Glucocorticoids, and Etoposide in Osteoblasts and the Osteocyte-Like Cell Line Murine Long Bone Osteocyte-Y4 |
Q34980894 | CD40 and its viral mimic, LMP1: similar means to different ends |
Q39311520 | CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c-Jun N terminal kinase activation independent from the interferon pathway |
Q34266298 | CD40 ligand (CD154) and tumour necrosis factor-related apoptosis inducing ligand (Apo-2L) in haematological malignancies |
Q52666648 | CD40 ligand deficiency causes functional defects of peripheral neutrophils that are improved by exogenous IFN-γ. |
Q39731032 | CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus |
Q45857463 | CD40 ligand mutants responsible for X-linked hyper-IgM syndrome associate with wild type CD40 ligand |
Q47873933 | CD40 ligand-dependent signaling of bovine B lymphocyte development and differentiation |
Q35793488 | CD40 ligation induces tissue factor expression in human vascular smooth muscle cells |
Q41134276 | CD40-CD40 ligand: a multifunctional receptor-ligand pair. |
Q41788290 | CD40-CD40L interaction in immunity against protozoan infections |
Q90669240 | CD40L Priming of Platelets via NF-κB Activation is CD40- and TAK1-Dependent |
Q33814059 | CD40L and Its Receptors in Atherothrombosis-An Update |
Q42811066 | CD40L stimulation enhances the ability of conventional metaphase cytogenetics to detect chromosome aberrations in B-cell chronic lymphocytic leukaemia cells |
Q28731004 | Chronic immune activation in HIV-1 infection contributes to reduced interferon alpha production via enhanced CD40:CD40 ligand interaction |
Q38628139 | Circulating CD40 and sCD40L Predict Changes in Renal Function in Subjects with Chronic Kidney Disease |
Q57075392 | Clinical spectrum of X-linked hyper-IgM syndrome |
Q27666816 | Crystallographic and Mutational Analysis of the CD40-CD154 Complex and Its Implications for Receptor Activation |
Q73895290 | Determination of the frequency of HLA antibody secreting B-lymphocytes in alloantigen sensitized individuals |
Q24563090 | Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells |
Q33377577 | Ectopic expression of a truncated CD40L protein from synthetic post-transcriptionally capped RNA in dendritic cells induces high levels of IL-12 secretion |
Q46953712 | Enhancement of binding activity of soluble human CD40 to CD40 ligand through incorporation of an isoleucine zipper motif |
Q34517239 | Excess soluble CD40L contributes to blood brain barrier permeability in vivo: implications for HIV-associated neurocognitive disorders |
Q36367835 | Expression of stromelysin-3 in atherosclerotic lesions: regulation via CD40-CD40 ligand signaling in vitro and in vivo |
Q37374541 | Functional CD40 ligand is expressed by T cells in rheumatoid arthritis |
Q36028683 | Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis |
Q44459472 | Gene transfer of the CD40-ligand to human dendritic cells induces NK-mediated antitumor effects against human carcinoma cells |
Q40314779 | Generation of a multimeric form of CD40L with potent immunostimulatory activity using streptavidin as a chaperon |
Q40916167 | Generation of a soluble recombinant trimeric form of bovine CD40L and its potential use as a vaccine adjuvant in cows |
Q34134411 | HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients |
Q51243205 | Help to go: T cells transfer CD40L to antigen-presenting B cells. |
Q71973601 | Heteromultimeric complexes of CD40 ligand are present on the cell surface of human T lymphocytes |
Q41216181 | Human native soluble CD40L is a biologically active trimer, processed inside microsomes |
Q43832218 | Identification of CD40 ligand in Alzheimer's disease and in animal models of Alzheimer's disease and brain injury |
Q38287944 | Incorporation of native antibodies and Fc-fusion proteins on DNA nanostructures via a modular conjugation strategy. |
Q36497627 | Increased synthesis of anti-tuberculous glycolipid immunoglobulin G (IgG) and IgA with cavity formation in patients with pulmonary tuberculosis |
Q52031885 | Inhibition of a secondary human alloimmune response via the soluble active component of CD154 (CD40L) in severe combined immune-deficient mice engrafted with human lymphocytes. |
Q37474929 | Molecular mechanism and function of CD40/CD40L engagement in the immune system. |
Q43182095 | New frontiers for platelet CD154. |
Q33183129 | Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. |
Q45761014 | Production of canine soluble CD40 ligand to induce maturation of monocyte derived dendritic cells for cancer immunotherapy. |
Q35913436 | Reduced pathology following infection with transgenic Leishmania major expressing murine CD40 ligand |
Q28484266 | Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells |
Q44522206 | Sequence context strongly modulates association of polar residues in transmembrane helices |
Q47661976 | Small-Molecule Inhibitors of the CD40-CD40L Costimulatory Protein-Protein Interaction |
Q48784822 | Soluble CD40 ligand (sCD40L) provides a new delivery system for targeted treatment: sCD40L-caspase 3 chimeric protein for treating B-cell malignancies |
Q35772650 | Soluble CD40 ligand contributes to dendritic cell-mediated T-cell dysfunction in HIV-1 infection |
Q34778615 | Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst |
Q42212835 | Soluble CD40-ligand (sCD40L, sCD154) plays an immunosuppressive role via regulatory T cell expansion in HIV infection. |
Q50768820 | Synergistic antibody induction by antigen-CD40 ligand fusion protein as improved immunogen. |
Q35754623 | T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation |
Q37433321 | TNF and TNF receptor superfamily members in HIV infection: new cellular targets for therapy? |
Q35534271 | TNF superfamily protein-protein interactions: feasibility of small- molecule modulation |
Q27010594 | Targeting platelet-derived soluble CD40 ligand: a new treatment strategy for HIV-associated neuroinflammation? |
Q33711057 | The CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells |
Q40289291 | The immunohistology of CD40 in human oral epithelium in health and disease |
Q36745762 | The promiscuous protein binding ability of erythrosine B studied by metachromasy (metachromasia). |
Q33858548 | The soluble CD40 ligand sCD154 in systemic lupus erythematosus |
Q39605867 | The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer |
Q36316025 | Titratable Avidity Reduction Enhances Affinity Discrimination in Mammalian Cellular Selections of Yeast-Displayed Ligands |
Q88922346 | Toward Small-Molecule Inhibition of Protein-Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions |
Q40314864 | Transfection and ligation of CD40 in human oral keratinocytes affect proliferation, adhesion and migration but not apoptosis in vitro |
Q40325737 | Transfection of CD40 in a human oral squamous cell carcinoma keratinocyte line upregulates immune potency and costimulatory molecules |
Q41945771 | Transfection of Trypanosoma cruzi with host CD40 ligand results in improved control of parasite infection |
Q37828473 | Tuning of CD40-CD154 interactions in human B-lymphocyte activation: a broad array of in vitro models for a complex in vivo situation |
Q28972255 | Update on the hyper immunoglobulin M syndromes |
Q33883558 | VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth |
Q28300434 | Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis |
Q64960314 | [Platelets cytokines and their effects on platelet transfusion]. |